Lexaria Bioscience (LEXX) Stock Price, Quote, News & History | Benzinga

Lexaria Bioscience Corp (LEXX) Stock Price, Quote, News & History

LEXXNASDAQ

Trade with Public

Trade with Public

$10.91

-0.36-3.15%

At close: Aug 21, 5:00 PM EST

$10.81

-0.11-0.97%

After Hours: 4:59 PM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Stock Report

Key Statistics

Open

$11.38

Close

$10.92

Volume / Avg.

8.92K / 15.30K

Day Range

$10.80 - $11.53

52 Wk Range

4.21 - 23.25

Market Cap

$17.86M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

66

Short Interest

15.33%

Days to Cover

1.4

Recent Lexaria Bioscience Corp News

Lexaria Bioscience Stock Rallies Thursday: What Investors Need to Know

Lexaria Bioscience shares are surging Thursday afternoon after announcing a new Material Transfer Agreement with Hong Kong-listed PegBio.

Henry Khederian

Why Bark Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Capital One Financial To Rally More Than 24%? Here Are Top Analyst Forecasts For Friday

Avi Kapoor

Lexaria Says Oral GLP-1 Cuts Side Effects Nearly 50% Versus Novo Nordisk's Rybelsus

Lexaria says its oral GLP-1 cut total adverse events nearly 48% versus Novo's Rybelsus, with comparable HbA1c results in a Phase 1b study.

Vandana Singh

Nasdaq Gains 100 Points; US Consumer Sentiment Falls

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 100 points on Friday. The Dow traded up 0.83% to 46,328.48 while the NASDAQ rose 0.45% to 22,484.92. The S&P 500 also rose, gaining, 0.62% to 6,645.73.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-7.43M

Investing Cash Flow (TTM)

-243.98K

Financing Cash Flow (TTM)

6.52M

Free Cash Flow (TTM)

-7.53M

Capital Expenditure (TTM)

-101.87K

Net Change in Cash (TTM)

-1.15M

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$15.41M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

88.81

PB Ratio (TTM)

4.00

Earnings Yield % (TTM)

-44.50%

Earnings Yield % (FWD)

-40.58%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$2.87

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$3.48M

Debt to Equity

0.02

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$11.38

Close

$10.92

Volume / Avg.

8.92K / 15.30K

Day Range

$10.80 - $11.53

52 Wk Range

4.21 - 23.25

Market Cap

$17.86M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

66

Short Interest

15.33%

Days to Cover

1.4

About

Sector

Health Care

Industry

Pharmaceuticals

Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Lexaria Bioscience (LEXX) stock?

A

You can purchase shares of Lexaria Bioscience (NASDAQ:LEXX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Lexaria Bioscience (LEXX) competitors?

A

Other companies in Lexaria Bioscience’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).

Q

What is the forecast, or price target, for Lexaria Bioscience (LEXX) stock?

A

Lexaria Bioscience has a consensus price target of $6.75.

Q

What is the current price for Lexaria Bioscience (LEXX)?

A

The stock price for Lexaria Bioscience (NASDAQ: LEXX) is $10.809 last updated August 21, 2026 at 4:59 PM EDT.

Q

Does Lexaria Bioscience (LEXX) pay a dividend?

A

There are no upcoming dividends for Lexaria Bioscience.

Q

When is Lexaria Bioscience (NASDAQ:LEXX) reporting earnings?

A

Lexaria Bioscience does not have any upcoming earnings scheduled.

Q

Is Lexaria Bioscience (LEXX) going to split?

A

There is no upcoming split for Lexaria Bioscience.

Q

What sector and industry does Lexaria Bioscience (LEXX) operate in?

A

Lexaria Bioscience is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.